Holiferm

Transforming industries with sustainable, highly performing biosurfactants derived from fermentation

Founded 2018

Birkenhead, United Kingdom 72 employees Series B Total: $28.67M Biotechnology, Industrial +1

General Information

Company Name Holiferm

Founded Year 2018

Location

Birkenhead, United Kingdom

Employees 72

Industries Biotechnology, Industrial, Pharmaceutical

Funding Stage Series B

Business Model B2B, D2C, White Label

Revenue Model Product Sales, Service Fee, Licensing

Offices as of Oct 2026

Birkenhead, United Kingdom Manchester, United Kingdom

Social

BounceWatch is an independent company data service, not affiliated with Holiferm. To contact Holiferm, visit holiferm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Holiferm compare?

A PDF of Holiferm and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Holiferm soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 21, 2026

Holiferm's Rafa is attending and representing the company at Cosmetorium in Barcelona, engaging attendees at stand 718 to discuss new biosurfactant developments.

Market Expansion Oct 19, 2026

Holiferm announced a strategic focus on the Asia Pacific market for personal care products during an upcoming webinar.

Tech Stack Change Oct 11, 2026

Moved their DNS to Cloudflare DNS.

Product Launch Oct 09, 2026

Holiferm has launched GranuSurf LF, a new granulated lactonic sophorolipid biosurfactant designed for powdered hard surface cleaners.

New Partnership Sep 25, 2026

Holiferm is a partner in the TEX4GREEN Project, developing glycolipid biosurfactants tailored for textile use.

Get alerts when Holiferm shows new signals

About Holiferm

Holiferm is revolutionizing industries with its commitment to sustainability through the production of eco-friendly biosurfactants. Founded in 2018, the company champions innovation in the Biotechnology, Industrial, and Pharmaceutical sectors. Operating out of its 1.6 ktonne scale biosurfactant manufacturing plant in Liverpool and a research facility in Manchester, United Kingdom, Holiferm addresses diverse manufacturing and R&D needs.

The company has recently secured a significant £18.50M Series B investment as of 01 January 2024, with pivotal backing from Rhapsody Venture Partners and Clean Growth Fund. This capital injection is poised to expand their scale and meet the burgeoning demand for sustainable solutions. Holiferm is strategically positioned to leverage its unique biosurfactant technology, addressing global sustainability challenges while offering investors substantial growth potential in a rapidly evolving market landscape.

Business keywords: biosurfactants, fermentation, sustainable manufacturing, innovative processes, green technology, sophorolipid production, customer support, Liverpool manufacturing plant, Manchester R&D facility, industrial biotechnology, clean technology, sustainable chemistry

Services & Products

Development of Advanced Biomanufacturing Processes

Production of Eco-Friendly Surfactants

Collaboration on Chemical Formulation and Scaling

Target Customers

Personal Care Product Manufacturers Home Care Product Companies Agricultural Enterprises Eco-Conscious Brands

Funding Rounds & Investors (7)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	£18.50M	2	Rhapsody Venture Partners, Clean Growth Fund	01 Jan 2024
Early VC	£2.00M	1	Greater Manchester Combined Authority	01 Jul 2023
Early VC	$7.00M	1	Rhapsody Venture Partners	01 Oct 2021
Grant	£950.00K	-		01 Jan 2020
Grant	£210.00K	1	Innovate UK	01 Jul 2019
Spinout	Undisclosed	1	University Ventures	01 Dec 2018
Grant	£10.00K	1	Biotechnology and Biological Sciences Research Council (BBSRC)	01 May 2018

Holiferm Alternatives & Competitors

View All Alternatives

Holiferm vs

BRAIN Biotech AG Germany

Developing a biobased future is our passion. Industrial biotechnology is our business.

Post-IPO Debt

178 employees

Biotechnology, Food and Beverage

Compare Holiferm vs BRAIN Biotech AG

Holiferm vs

Mironova Labs United States

Small molecule innovation since 1988.

11 employees

Biotechnology, Pharmaceutical

Compare Holiferm vs Mironova Labs

Holiferm vs

Pyran Inc. United States

Unlocking 5 Carbon Chemistry

Venture round

13 employees

Biotechnology, Industrial

View all alternatives

FAQ About Holiferm

Transforming industries with sustainable, highly performing biosurfactants derived from fermentation

Holiferm was founded in 2018.

Holiferm is headquartered in Birkenhead, United Kingdom. As of Oct 2026, it also has offices in Manchester, United Kingdom.

Holiferm operates in Biotechnology, Industrial and Pharmaceutical. Its work centres on biosurfactants, fermentation, sustainable manufacturing and innovative processes. Its customers include Personal Care Product Manufacturers, Home Care Product Companies and Agricultural Enterprises.

Holiferm has a B2B, D2C and White Label business model. Its revenue comes from Product Sales, Service Fee and Licensing.

Holiferm has approximately 72 employees.

Holiferm has completed 7 funding rounds, raising a total of $28.67M. The latest funding stage is Series B.

Holiferm offers: Development of Advanced Biomanufacturing Processes, Production of Eco-Friendly Surfactants, Collaboration on Chemical Formulation and Scaling.

Top alternatives and competitors to Holiferm include BRAIN Biotech AG, Mironova Labs, Pyran Inc., Again, Phytonix Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Holiferm and BRAIN Biotech AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Holiferm, https://bouncewatch.com/company/holiferm, updated 12 October 2026. When citing, please name BounceWatch and link this page.

Holiferm

General Information

Discover More

What changed at Holiferm recently?

About Holiferm

Services & Products

Target Customers

Funding Rounds & Investors (7)

Holiferm Alternatives & Competitors

FAQ About Holiferm